Moreover, the upregulation of IL-10 secretion by CD4+CD25+ICOS+ Tregs indicated that the expansion of Tregs in AML could be achieved through the ICOS/ICOSL pathway, which enhances the body’s immunosuppressive ability and induces leukemia cells to immune escape and drug resistance (Figure 2). Here, ICOS is linked to acute myeloid leukemia.